How do AF comorbidity patterns change care and outcomes?

Open paper intelligence

In 32,560 AF patients, six comorbidity phenotypes ranged from low complexity to high complexity, with cardiometabolic/high-complexity groups facing higher event risk despite more anticoagulation.

Source

Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry

Romiti GF, Corica B, Mei DA, et al. · BMC medicine · 2024

doi.org/10.1186/s12916-024-03373-4 Read the full paper ↗56 citationscc by

Study at a glance

Design: Cohort — Prospective Global GLORIA-AF Registry comorbidity phenotype analysis
N: N=32560 · AF patients; mean age 70.0 ± 10.5 years; 45.4% female
Population: Adults with atrial fibrillation in a global prospective registry
Outcome: Comorbidity phenotypes linked to management and long-term prognosis

Structured fields used in claim comparison tables when every cited study has a complete layer.

What they did

Analyzed the Prospective Global GLORIA-AF Registry to cluster comorbidity phenotypes and relate them to oral anticoagulant/rate-control use and long-term primary outcomes.

What they found

Six phenotypes: low complexity (39.2%), CV risk factors (28.2%), atherosclerotic (10.2%), thromboembolic (8.1%), cardiometabolic (7.6%), high complexity (6.6%). More complex groups used more OACs; cardiometabolic and high-complexity groups had the highest primary-outcome HRs (~1.37 and ~1.47).

The limits

What it doesn't show

Registry observational associations cannot prove that changing phenotype classification improves outcomes; residual confounding and regional practice variation remain.

Key terms

Atrial fibrillation: Irregular atrial rhythm with stroke and heart-failure risk.
Multimorbidity: Two or more concurrent chronic conditions.
Clinical complexity: Interplay of multimorbidity, ageing, frailty, polypharmacy.
Phenotype: Clustered comorbidity pattern within AF patients.
GLORIA-AF: Global prospective AF registry.
Oral anticoagulant: Medication used for stroke prevention in AF.

Flashcards

1 / 8

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 5

GLORIA-AF analytic N?

Common questions

32,560 AF patients.

Largest phenotype?

Low complexity (39.2%).

Highest-risk phenotypes?

Cardiometabolic and high complexity.

OAC use pattern?

Higher in more complex groups.